Skip to Content

Rozerem Takeda Pharmaceuticals North America, Inc. - Treatment for Insomnia

Rozerem is the first and only prescription sleep medication that has shown no evidence of abuse and dependence, and is therefore not designated as a controlled substance. Rozerem is indicated for the treatment of adults with insomnia characterized by difficulty with sleep onset, and can be prescribed for long-term use. Aczone (dapsone) Gel 5%

Posted: July 2005

Related Articles:

Rozerem (ramelteon) FDA Approval History